{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:24:25Z","timestamp":1791494665288,"version":"4.3.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T00:00:00Z","timestamp":1551052800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1038\/s41409-019-0480-x","type":"journal-article","created":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T11:03:40Z","timestamp":1551092620000},"page":"1625-1631","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Autologous stem cell transplantation for HIV-associated lymphoma in the antiretroviral and rituximab era: a retrospective study by the EBMT Lymphoma Working Party"],"prefix":"10.1038","volume":"54","author":[{"given":"Kai","family":"H\u00fcbel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"Boumendil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herve","family":"Finel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Hentrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Wyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariagrazia","family":"Michieli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Kanfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"Diez-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascual","family":"Balsalobre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5904-1286","authenticated-orcid":false,"given":"Laure","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfried","family":"Schroyens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep Maria Ribera","family":"Santasusana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolaus","family":"Kr\u00f6ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xaver","family":"Schiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Cwynarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Esquirol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida Botelho","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Cattaneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Montoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Dreger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,25]]},"reference":[{"key":"480_CR1","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1093\/jnci\/djr076","volume":"103","author":"MS Shiels","year":"2011","unstructured":"Shiels MS, Pfeiffer RM, Gail MH, Hall HI, Li J, Chaturvedi AK, et al. Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst. 2011;103:753\u201362.","journal-title":"J Natl Cancer Inst"},{"key":"480_CR2","doi-asserted-by":"crossref","unstructured":"Morlat P, Roussillon C, Henard S, Salmon D, Bonnet F, Cacoub P, et al. Causes of death among HIV-infected patients in France in 2010 (national survey): trends since 2000. AIDS. 2014;28(8):1181\u201391.","DOI":"10.1097\/QAD.0000000000000222"},{"key":"480_CR3","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1200\/JCO.2008.19.6626","volume":"27","author":"T Powles","year":"2009","unstructured":"Powles T, Robinson D, Stebbing J, Shamash J, Nelson M, Gazzard B, et al. Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection. J Clin Oncol. 2009;27:884\u201390.","journal-title":"J Clin Oncol"},{"key":"480_CR4","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1097\/CCO.0b013e3283560697","volume":"24","author":"JJ Goedert","year":"2012","unstructured":"Goedert JJ, Bower M. Impact of highly effective antiretroviral therapy on the risk for Hodgkin lymphoma among people with human immunodeficiency virus infection. Curr Opin Oncol. 2012;24:531\u20136.","journal-title":"Curr Opin Oncol"},{"key":"480_CR5","doi-asserted-by":"publisher","first-page":"3786","DOI":"10.1182\/blood-2006-05-024109","volume":"108","author":"RJ Biggar","year":"2006","unstructured":"Biggar RJ, Jaffe ES, Goedert JJ, Chaturvedi A, Pfeiffer R, Engels EA. Hodgkin lymphoma and immunodeficiency in persons with HIV\/AIDS. Blood. 2006;108:3786\u201391.","journal-title":"Blood"},{"key":"480_CR6","doi-asserted-by":"publisher","first-page":"4111","DOI":"10.1200\/JCO.2011.41.4193","volume":"30","author":"S Montoto","year":"2012","unstructured":"Montoto S, Shaw K, Okosun J, Gandhi S, Fields P, Wilson A, et al. HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era. J Clin Oncol. 2012;30:4111\u20136.","journal-title":"J Clin Oncol"},{"key":"480_CR7","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1002\/cncr.27918","volume":"119","author":"JM Ribera","year":"2013","unstructured":"Ribera JM, Garcia O, Grande C, Esteve J, Oriol A, Bergua J, et al. Dose-intensive chemotherapy including rituximab in Burkitt\u2019s leukemia or lymphoma regardless of human immunodeficiency virus infection status: final results of a phase 2 study (Burkimab). Cancer. 2013;119:1660\u20138.","journal-title":"Cancer"},{"key":"480_CR8","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1097\/QAD.0000000000000133","volume":"28","author":"R Coutinho","year":"2014","unstructured":"Coutinho R, Pria AD, Gandhi S, Bailey K, Fields P, Cwynarski K, et al. HIV status does not impair the outcome of patients diagnosed with diffuse large B-cell lymphoma treated with R-CHOP in the cART era. AIDS. 2014;28:689\u201397.","journal-title":"AIDS"},{"key":"480_CR9","doi-asserted-by":"publisher","first-page":"857","DOI":"10.3324\/haematol.2017.180893","volume":"103","author":"P Schommers","year":"2018","unstructured":"Schommers P, Gillor D, Hentrich M, Wyen C, Wolf T, Oette M, et al. Incidence and risk factors for relapses in HIV-associated non-Hodgkin lymphoma as observed in the German HIV-related lymphoma cohort study. Haematologica. 2018;103:857\u201364.","journal-title":"Haematologica"},{"key":"480_CR10","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1111\/bjh.13221","volume":"168","author":"P Schommers","year":"2015","unstructured":"Schommers P, Hentrich M, Hoffmann C, Gillor D, Zoufaly A, Jensen B, et al. Survival of AIDS-related diffuse large B-cell lymphoma, Burkitt lymphoma, and plasmablastic lymphoma in the German HIV Lymphoma Cohort. Br J Haematol. 2015;168:806\u201310.","journal-title":"Br J Haematol"},{"key":"480_CR11","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1182\/blood-2015-08-664706","volume":"128","author":"JC Alvarnas","year":"2016","unstructured":"Alvarnas JC, Le Rademacher J, Wang Y, Little RF, Akpek G, Ayala E, et al. Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803\/AMC 071 trial. Blood. 2016;128:1050\u20138.","journal-title":"Blood"},{"key":"480_CR12","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1200\/JCO.2008.18.2683","volume":"27","author":"P Balsalobre","year":"2009","unstructured":"Balsalobre P, Diez-Martin JL, Re A, Michieli M, Ribera JM, Canals C, et al. Autologous stem-cell transplantation in patients with HIV-related lymphoma. J Clin Oncol. 2009;27:2192\u20138.","journal-title":"J Clin Oncol"},{"key":"480_CR13","doi-asserted-by":"publisher","first-page":"6011","DOI":"10.1182\/blood-2008-12-195388","volume":"113","author":"JL Diez-Martin","year":"2009","unstructured":"Diez-Martin JL, Balsalobre P, Re A, Michieli M, Ribera JM, Canals C, et al. Comparable survival between HIV+ and HIV- non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation. Blood. 2009;113:6011\u20134.","journal-title":"Blood"},{"key":"480_CR14","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1038\/bmt.2016.219","volume":"51","author":"R Ramaswami","year":"2016","unstructured":"Ramaswami R, Pria AD, Parker K, McCann S, Kanfer EJ, Nelson M, et al. Outcomes of autologous stem cell transplantation (ASCT) in patients with relapsed\/refractory HIV-associated lymphoma. Bone Marrow Transplant. 2016;51:1609\u201311.","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 5","key":"480_CR15","doi-asserted-by":"publisher","first-page":"v116","DOI":"10.1093\/annonc\/mdv304","volume":"26","author":"H Tilly","year":"2015","unstructured":"Tilly H, Gomes da Silva M, Vitolo U, Jack A, Meignan M, Lopez-Guillermo A, et al. Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(Suppl 5):v116\u201325.","journal-title":"Ann Oncol"},{"issue":"Suppl 3","key":"480_CR16","doi-asserted-by":"publisher","first-page":"iii70","DOI":"10.1093\/annonc\/mdu181","volume":"25","author":"DA Eichenauer","year":"2014","unstructured":"Eichenauer DA, Engert A, Andre M, Federico M, Illidge T, Hutchings M, et al. Hodgkin\u2019s lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;25(Suppl 3):iii70\u20135.","journal-title":"Ann Oncol"},{"key":"480_CR17","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1038\/bmt.2015.6","volume":"50","author":"A Sureda","year":"2015","unstructured":"Sureda A, Bader P, Cesaro S, Dreger P, Duarte RF, Dufour C, et al. Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015. Bone Marrow Transplant. 2015;50:1037\u201356.","journal-title":"Bone Marrow Transplant"},{"key":"480_CR18","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/S0140-6736(00)02041-9","volume":"355","author":"J Gabarre","year":"2000","unstructured":"Gabarre J, Azar N, Autran B, Katlama C, Leblond V. High-dose therapy and autologous haematopoietic stem-cell transplantation for HIV-1-associated lymphoma. Lancet. 2000;355:1071\u20132.","journal-title":"Lancet"},{"key":"480_CR19","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1182\/blood-2004-04-1532","volume":"105","author":"A Krishnan","year":"2005","unstructured":"Krishnan A, Molina A, Zaia J, Smith D, Vasquez D, Kogut N, et al. Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas. Blood. 2005;105:874\u20138.","journal-title":"Blood"},{"key":"480_CR20","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.bbmt.2011.10.010","volume":"18","author":"N Mounier","year":"2012","unstructured":"Mounier N, Canals C, Gisselbrecht C, Cornelissen J, Foa R, Conde E, et al. High-dose therapy and autologous stem cell transplantation in first relapse for diffuse large B cell lymphoma in the rituximab era: an analysis based on data from the European Blood and Marrow Transplantation Registry. Biol Blood Marrow Transplant. 2012;18:788\u201393.","journal-title":"Biol Blood Marrow Transplant"},{"key":"480_CR21","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/bmt.2015.286","volume":"51","author":"SP Robinson","year":"2016","unstructured":"Robinson SP, Boumendil A, Finel H, Blaise D, Poire X, Nicolas-Virelizier E, et al. Autologous stem cell transplantation for relapsed\/refractory diffuse large B-cell lymphoma: efficacy in the rituximab era and comparison to first allogeneic transplants. A report from the EBMT Lymphoma Working Party. Bone Marrow Transplant. 2016;51:365\u201371.","journal-title":"Bone Marrow Transplant"},{"key":"480_CR22","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.bbmt.2014.06.036","volume":"20","author":"M Hamadani","year":"2014","unstructured":"Hamadani M, Hari PN, Zhang Y, Carreras J, Akpek G, Aljurf MD, et al. Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2014;20:1729\u201336.","journal-title":"Biol Blood Marrow Transplant"},{"key":"480_CR23","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1093\/annonc\/mdi248","volume":"16","author":"A Josting","year":"2005","unstructured":"Josting A, Sieniawski M, Glossmann JP, Staak O, Nogova L, Peters N, et al. High-dose sequential chemotherapy followed by autologous stem cell transplantation in relapsed and refractory aggressive non-Hodgkin\u2019s lymphoma: results of a multicenter phase II study. Annals Oncol. 2005;16:1359\u201365.","journal-title":"Annals Oncol"},{"key":"480_CR24","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/bmt.2015.273","volume":"51","author":"L Sellner","year":"2016","unstructured":"Sellner L, Boumendil A, Finel H, Choquet S, de Rosa G, Falzetti F, et al. Thiotepa-based high-dose therapy for autologous stem cell transplantation in lymphoma: a retrospective study from the EBMT. Bone Marrow Transplant. 2016;51:212\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"480_CR25","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.bbmt.2015.03.008","volume":"21","author":"C Cattaneo","year":"2015","unstructured":"Cattaneo C, Finel H, McQuaker G, Vandenberghe E, Rossi G, Dreger P. Autologous hematopoietic stem cell transplantation for plasmablastic lymphoma: the European Society for Blood and Marrow Transplantation experience. Biol Blood Marrow Transplant. 2015;21:1146\u20137.","journal-title":"Biol Blood Marrow Transplant"},{"key":"480_CR26","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/bmt.2017.230","volume":"53","author":"A Re","year":"2018","unstructured":"Re A, Gini G, Rupolo M, Levis A, Bandera A, Liberati AM, et al. Early consolidation with high-dose therapy and autologous stem cell transplantation is a feasible and effective treatment option in HIV-associated non-Hodgkin lymphoma at high risk. Bone Marrow Transplant. 2018;53:228\u201330.","journal-title":"Bone Marrow Transplant"},{"key":"480_CR27","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1159\/000458443","volume":"40","author":"T Welz","year":"2017","unstructured":"Welz T, Wyen C, Hensel M. Drug interactions in the treatment of malignancy in HIV-infected patients. Oncol Res Treat. 2017;40:120\u20137.","journal-title":"Oncol Res Treat"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41409-019-0480-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-019-0480-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-019-0480-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:14:13Z","timestamp":1684602853000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-019-0480-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,25]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["480"],"URL":"https:\/\/doi.org\/10.1038\/s41409-019-0480-x","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,25]]},"assertion":[{"value":"4 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}